CorVel Corp. 10-Q Summary: Quarter Ended December 31, 1997
Business Context and Reporting Period
This Form 10-Q covers the third quarter and nine-month period ended December 31, 1997, for CorVel Corporation, a provider of workers' compensation managed care services. The company operates primarily in patient management and provider network services. As of December 31, 1997, there were 4,130,000 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 1997 | Nine Months Ended Dec 31, 1997 |
|---|---|---|
| Revenues | $35,558,000 | $104,265,000 |
| Net Income | $2,395,000 | $7,051,000 |
| Diluted EPS | $0.56 | $1.63 |
| Gross Margin | 18.5% | 18.7% |
| Operating Cash Flow (9mo) | $9,199,000 | |
| Cash and Equivalents (End of Period) | $11,080,000 | |
| Total Assets | $58,859,000 | |
| Total Liabilities | $13,819,000 |
The filing does not disclose long-term debt; liabilities consist primarily of current obligations (accounts payable and accrued liabilities) and deferred income taxes.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 17% for the quarter and 16% for the nine-month period compared to the prior year. This was driven by a 29% increase in patient management revenue (quarterly) and a 26% increase (nine-month), attributed to new national case management contracts.
- Profitability: Net income rose 10% for the quarter and 12% for the nine-month period. However, net income as a percentage of revenue declined slightly from 7.1% to 6.7% for the quarter.
- Expenses: General and administrative expenses increased as a percentage of revenue (from 7.1% to 7.7% for the quarter), largely due to costs associated with installing a wide area network (WAN).
- Liquidity: Net working capital decreased by $4.2 million to $24.4 million. Cash and cash equivalents declined from $15.7 million to $11.1 million, primarily due to the repurchase of $9.5 million in treasury stock during the nine-month period.
Outlook, Risks, and Management Commentary
Management anticipates that current cash balances and internally generated funds will be sufficient to meet requirements for the next twelve months. The company plans to continue internal growth and may pursue strategic acquisitions, potentially financed through working capital, debt, or equity.
Key Risks Identified:
- Regulatory Changes: Evolving state laws regarding medical review services and managed care networks could increase operational costs or limit market access.
- Competition: Intensifying competition from large insurers, HMOs, and PPOs, particularly as legislation allows these entities to manage workers' compensation claims.
- Market Dynamics: Declines in workers' compensation claim volumes and costs in certain states could reduce demand for the company's services.
- Legal Liability: Potential exposure to litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
Investor Verification Checklist
- Verify the sustainability of the 29% growth in patient management revenue and the renewal status of the new national contracts.
- Monitor the impact of WAN installation costs on future general and administrative expense ratios.
- Assess the company's cash burn rate relative to the $11.1 million cash balance given the aggressive $9.5 million stock buyback program.
- Review state-specific regulatory updates regarding medical review licensing and managed care network oversight.
- Confirm the status of ongoing litigation and whether insurance coverage remains adequate for potential liabilities.